Single dose kinetics of mefloquine in man. Plasma levels of the unchanged drug and of one of its metabolites.
Oral single dose kinetics of mefloquine was investigated in 16 male volunteers, 3 Caucasians and 13 African natives. Unchanged mefloquine (= M) and one of its metabolites (= MM) were measured in the plasma. The apparent half-life of absorption of M ranged from 0.36 to 2.0 h, its terminal half-life of elimination from 15 to 33 days. Assuming complete systemic availability, an apparent volume of distribution of 14-29 liters x kg-1 and a total clearance of 18-39 ml x min-1 were derived. MM given orally to mice or rats showed at equal dose the same tolerance as mefloquine. Following oral administration of M to man, plasma levels of MM surpassed those of M, resulting in a 2.4-5.1 larger AUC. However, because of its much smaller apparent volume of distribution, MM may be anticipated to represent only a small percentage of the dose and therefore to contribute only to a minor extent towards the unwanted side effects of the drug.
D000328:Adult; D001711:Biotransformation; D001798:Blood Proteins / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D015767:Mefloquine; D008875:Middle Aged; D010880:Piperidines / Q000097:blood / Q000378:metabolism*; D011485:Protein Binding; D011804:Quinolines / Q000097:blood / Q000378:metabolism*; D013997:Time Factors
D001798:Blood Proteins; D010880:Piperidines; D011804:Quinolines; D015767:Mefloquine